Abstract

The way alternative splicing is regulated within tissues is not understood. A relevant model of this process is provided by fibronectin, an important extracellular matrix protein that plays a key role in cell adhesion and migration and contains three alternatively spliced regions known as EDI, EDII, and IIICS. We used a cell culture system to simulate mammary epithelial-stromal communication, a process that is crucial for patterning and function of the mammary gland, and studied the effects of extracellular signals on the regulation of fibronectin pre-mRNA alternative splicing. We found that soluble factors from a mammary mesenchymal cell-conditioned medium, as well as the growth factors HGF/SF (hepatocyte growth factor/scatter factor), KGF (keratinocyte growth factor), and aFGF (acidic fibroblast growth factor), stimulate EDI and IIICS but not EDII inclusion into fibronectin mRNA in the mammary epithelial cell line SCp2, favoring fibronectin isoforms associated with proliferation, migration, and tissue remodeling. We explored the signaling pathways involved in this regulation and found that the mammary mesenchymal cell-conditioned medium and HGF/SF act through a phosphatidylinositol 3-kinase-dependent cascade to alter fibronectin alternative splicing. This splicing regulation is independent from promoter structure and de novo protein synthesis but does require two exonic elements within EDI. These results shed light on how extracellular stimuli are converted into changes in splicing patterns.

Highlights

  • In vivo EDIϩ FN is poorly represented in the extracellular matrix (ECM) of adult normal tissues

  • In this study we investigated the effects of different growth factors and cytokines on FN alternative splicing in a functionally normal mouse mammary epithelial cell line (SCp2) and show that hepatocyte growth factor/scatter factor (HGF/SF), keratinocyte growth factor (KGF), and acidic FGF stimulate EDI and IIICS inclusion but not EDII into mature FN mRNA

  • We demonstrate that soluble factors secreted by a mouse mammary mesenchymal cell line (SCg6) present in the conditioned medium from these cells (g6CM) regulate FN EDI and IIICS alternative splicing in SCp2 cells, indicating that epithelial-mesenchymal interaction influences pre-mRNA alternative splicing

Read more

Summary

THE JOURNAL OF BIOLOGICAL CHEMISTRY

Vol 279, No 20, Issue of May 14, pp. 21029 –21037, 2004 Printed in U.S.A. Mammary Epithelial-Mesenchymal Interaction Regulates Fibronectin Alternative Splicing via Phosphatidylinositol 3-Kinase*. We explored the signaling pathways involved in this regulation and found that the mammary mesenchymal cell-conditioned medium and HGF/SF act through a phosphatidylinositol 3-kinase-dependent cascade to alter fibronectin alternative splicing. This splicing regulation is independent from promoter structure and de novo protein synthesis but does require two exonic elements within EDI. In vivo EDIϩ FN is poorly represented in the ECM of adult normal tissues This variant is over-expressed in developing embryos, wound healing, liver fibrosis, ovary granulosa cell proliferation, and some tumors [2, 3]. This paper is available on line at http://www.jbc.org

Regulation of Fibronectin Alternative Splicing
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.